Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canadian Latest policies Contact

Report an adverse reaction to a vaccine: Hospitals

Under the mandatory reporting requirements for hospitals, hospitals must report, in writing, within 30 days of documenting the serious adverse drug reaction within the facility. We encourage hospitals to report sooner, if possible.

Report a serious adverse reaction

Health care professionals who work in a hospital should check with their hospital administration to learn about any new requirements and internal procedures.

However, hospitals do not have to report an adverse reaction to a vaccine if they have submitted an Adverse Events Following Immunization (AEFI) report on that case to their local public health unit. Learn more about reporting adverse events following an immunization.

Tracking adverse events following immunization

Health Canada and the Public Health Agency of Canada (PHAC) share the monitoring of the safety of vaccines in Canada.

PHAC manages the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), which is a post-market vaccine safety surveillance system. CAEFISS reports are submitted by public health authorities in provinces and territories, which in turn receive them from local public health units. Nurses, doctors and pharmacists who provide immunizations or care for people who experience an adverse event from a vaccine generate most of these reports.

In addition, when manufacturers are made aware of adverse reactions to a drug or vaccine, they must report to Health Canada:

  • serious adverse reactions in Canada
  • unexpected serious adverse reactions in other countries
  • unusual failures in efficacy for new drugs in Canada
Manufacturers report to Health Canada's Canada Vigilance Program.
Text Equivalent

This diagram shows the reporting pathway of adverse events following immunization:

  • from the source (vaccine recipient or manufacturer)
  • to the Public Health Agency of Canada or Health Canada

At the top of the diagram, on the left, is a box representing the vaccine recipient. From this box, an arrow points downward to a box for the health care provider. From this box, an arrow points downward to a box for local public health units. From this box, an arrow points downward to a box for federal/provincial/territorial immunization authorities, then to a box for the Public Health Agency of Canada.

At the top of the diagram, on the right, is a box representing the vaccine recipient. From this box, an arrow points downward to a box for manufacturers. From this box, an arrow points downward to a box for Health Canada.

From the vaccine recipient box, an arrow points downward to the Health Canada box, indicating that the vaccine recipient can report directly to Health Canada. Another dotted line with double arrows points between the Public Health Agency of Canada box and the Health Canada box, indicating the Public Health Agency of Canada and Health Canada share information about adverse events.

At the bottom of the diagram is a box representing hospitals. From the left side of the box, a dotted line with a single arrow points to the Public Health Agency of Canada. From the right side of the box, a dotted line with a single arrow points to Health Canada.

Related links

Page details

2025-06-11

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us Chat on WhatsApp
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit